Archaeosomes display immunoadjuvant potential for a vaccine against Chagas disease

References

• The Special Programme for Research and Training in Tropical Diseases (TDR/WHO). Reporte sobre la Enfermedad de Chagas. Buenos Aires, Argentina. Guhl F, Ladzins-Helds JK, eds, 2007: 97.
   Google Scholar
• Garg N, Bhatia V. Current status and future prospects for a vaccine against American trypanosomiasis. Expert Rev Vaccines 2005; 4:867 - 80; http://dx.doi.org/10.1586/14760584.4.6.867; PMID: 16372882
   PubMed Web of Science ®Google Scholar
• Quijano-Hernandez I, Dumonteil E. Advances and challenges towards a vaccine against Chagas disease. Hum Vaccin 2011; 7:1184 - 91; http://dx.doi.org/10.4161/hv.7.11.17016; PMID: 22048121
   PubMed Web of Science ®Google Scholar
• Sprott GD, Tolson DL, Patel GB. Archaeosomes as novel antigen delivery systems. FEMS Microbiol Lett 1997; 154:17 - 22; http://dx.doi.org/10.1016/S0378-1097(97)00294-2; PMID: 9297816
   PubMed Web of Science ®Google Scholar
• Krishnan L, Dicaire CJ, Patel GB, Sprott GD. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum. Infect Immun 2000; 68:54 - 63; http://dx.doi.org/10.1128/IAI.68.1.54-63.2000; PMID: 10603368
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang L, Sun W, Ding Q, Hou Y, Xu Y. Archaeosomes with encapsulated antigens for oral vaccine delivery. Vaccine 2011; 29:5260 - 6; http://dx.doi.org/10.1016/j.vaccine.2011.05.015; PMID: 21609747
   PubMed Web of Science ®Google Scholar
• Sprott GD, Sad S, Fleming LP, Dicaire CJ, Patel GB, Krishnan L. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen. Archaea 2003; 1:151 - 64; http://dx.doi.org/10.1155/2003/569283; PMID: 15803661
   PubMedGoogle Scholar
• Krishnan L, Sad S, Patel GB, Sprott GD. The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in vivo. J Immunol 2001; 166:1885 - 93; PMID: 11160236
   PubMed Web of Science ®Google Scholar
• Nordly P, Korsholm KS, Pedersen EA, Khilji TS, Franzyk H, Jorgensen L, et al. Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo. Eur J Pharm Biopharm 2011; 77:89 - 98; http://dx.doi.org/10.1016/j.ejpb.2010.10.001; PMID: 20940050
   PubMed Web of Science ®Google Scholar
• González RO, Higa LH, Cutrullis RA, Bilen M, Morelli I, Roncaglia DI, et al. Archaeosomes made of Halorubrum tebenquichense total polar lipids: a new source of adjuvancy. BMC Biotechnol 2009; 9:71; http://dx.doi.org/10.1186/1472-6750-9-71; PMID: 19678953
   PubMed Web of Science ®Google Scholar
• Conlan JW, Krishnan L, Willick GE, Patel GB, Sprott GD. Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various Archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pathogen, Listeria monocytogenes.. Vaccine 2001; 19:3509 - 17; http://dx.doi.org/10.1016/S0264-410X(01)00041-X; PMID: 11348718
   PubMed Web of Science ®Google Scholar
• Segura EL, Vazquez C, Bronzina A, Campos JM, Cerisola JA, Gonzalez Cappa SM. Antigens of the subcellular fraction of Trypanosoma cruzi. Part II: Flagellar and membrane fraction. J Protozool 1997; 24:540 - 3
   Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248 - 54; http://dx.doi.org/10.1016/0003-2697(76)90527-3; PMID: 942051
   PubMed Web of Science ®Google Scholar
• Stewart JCM. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 1980; 104:10 - 4; http://dx.doi.org/10.1016/0003-2697(80)90269-9; PMID: 6892980
   PubMed Web of Science ®Google Scholar
• Corral RS, Petray PB. CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi.. Vaccine 2000; 19:234 - 42; http://dx.doi.org/10.1016/S0264-410X(00)00172-9; PMID: 10930678
   PubMed Web of Science ®Google Scholar
• Pizzi T. Prensa Médica Universitaria. Santiago de Chile, 1957, 38.
   Google Scholar
• Hoft DF, Eickhoff CS. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Infect Immun 2002; 70:6715 - 25; http://dx.doi.org/10.1128/IAI.70.12.6715-6725.2002; PMID: 12438346
   PubMed Web of Science ®Google Scholar
• Powell MR, Wassom DL. Host genetics and resistance to acute Trypanosoma cruzi infection in mice. I. Antibody isotype profiles. Parasite Immunol 1993; 15:215 - 21; http://dx.doi.org/10.1111/j.1365-3024.1993.tb00603.x; PMID: 8506117
   PubMed Web of Science ®Google Scholar
• Taliaferro WH, Pizzi T. Connective tissue reactions in normal and immunized mice to a reticulotropic strain of Trypanosoma cruzi.. J Infect Dis 1955; 96:199 - 226; http://dx.doi.org/10.1093/infdis/96.3.199; PMID: 14392366
   PubMed Web of Science ®Google Scholar
• Krishnan L, Gurnani K, Dicaire CJ, van Faassen H, Zafer A, Kirschning CJ, et al. Rapid clonal expansion and prolonged maintenance of memory CD8+ T cells of the effector (CD44highCD62Llow) and central (CD44highCD62Lhigh) phenotype by an archaeosome adjuvant independent of TLR2. J Immunol 2007; 178:2396 - 406; PMID: 17277146
   PubMed Web of Science ®Google Scholar
• de la Salle H, Mariotti S, Angenieux C, Gilleron M, Garcia-Alles L-F, Malm D, et al. Assistance of microbial glycolipid antigen processing by CD1e. Science 2005; 310:1321 - 4; http://dx.doi.org/10.1126/science.1115301; PMID: 16311334
   PubMed Web of Science ®Google Scholar
• Krishnan L, Sad S, Patel GB, Sprott GD. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help. J Immunol 2000; 165:5177 - 85; PMID: 11046050
   PubMed Web of Science ®Google Scholar
• Sprott GD, Dicaire CJ, Côté J-P, Whitfield DM. Adjuvant potential of archaeal synthetic glycolipid mimetics critically depends on the glyco head group structure. Glycobiology 2008; 18:559 - 65; http://dx.doi.org/10.1093/glycob/cwn038; PMID: 18450974
   PubMed Web of Science ®Google Scholar
• Higa LH, Schilrreff P, Perez AP, Iriarte MA, Roncaglia DI, Morilla MJ, et al. Ultradeformable archaeosomes as new topical adjuvants. Nanomedicine 2012; 8:1319 - 28; PMID: 22366598
   PubMed Web of Science ®Google Scholar
• Tarleton RL. Chagas disease: a role for autoimmunity?. Trends Parasitol 2003; 19:447 - 51; http://dx.doi.org/10.1016/j.pt.2003.08.008; PMID: 14519582
   PubMed Web of Science ®Google Scholar
• Esko JD, Doering TL, Raetz CRH. Eubacteria and Archaea. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, eds. Essentials of Glycobiology. 2nd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, 2009, Chapter 20.
   Google Scholar